|
1
|
Cleator S, Heller W and Coombes RC:
Triple-negative breast cancer: Therapeutic options. Lancet Oncol.
8:235–244. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dent R, Trudeau M, Pritchard KI, Hanna WM,
Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA:
Triple-negative breast cancer: Clinical features and patterns of
recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rakha EA, El-Sayed ME, Green AR, Lee AH,
Robertson JF and Ellis IO: Prognostic markers in triple-negative
breast cancer. Cancer. 109:25–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Keam B, Im SA, Lee KH, Han SW, Oh DY, Kim
JH, Lee SH, Han W, Kim DW, Kim TY, et al: Ki-67 can be used for
further classification of triple negative breast cancer into two
subtypes with different response and prognosis. Breast Cancer Res.
13:R222011. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bickel PE, Tansey JT and Welte MA: PAT
proteins, an ancient family of lipid droplet proteins that regulate
cellular lipid stores. Biochim Biophys Acta. 1791:419–440. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sztalryd C and Kimmel AR: Perilipins:
Lipid droplet coat proteins adapted for tissue-specific energy
storage and utilization, and lipid cytoprotection. Biochimie.
96:96–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sztalryd C and Brasaemle DL: The perilipin
family of lipid droplet proteins: Gatekeepers of intracellular
lipolysis. Biochim Biophys Acta Mol Cell Biol Lipids.
1862:1221–1232. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nitulescu GM, Van De Venter M, Nitulescu
G, Ungurianu A, Juzenas P, Peng Q, Olaru OT, Grădinaru D, Tsatsakis
A, Tsoukalas D, et al: The Akt pathway in oncology therapy and
beyond (Review). Int J Oncol. 53:2319–2331. 2018.PubMed/NCBI
|
|
9
|
Fujimoto M, Yoshizawa A, Sumiyoshi S,
Sonobe M, Menju T, Hirata M, Momose M, Date H and Haga H:
Adipophilin expression in lung adenocarcinoma is associated with
apocrine-like features and poor clinical prognosis: An
immunohistochemical study of 328 cases. Histopathology. 70:232–241.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hashimoto Y, Ishida M, Ryota H, Yamamoto
T, Kosaka H, Hirooka S, Yamaki S, Kotsuka M, Matsui Y, Yanagimoto
H, et al: Adipophilin expression is an indicator of poor prognosis
in patients with pancreatic ductal adenocarcinoma: An
immunohistochemical analysis. Pancreatology. 19:443–448. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yoshikawa K, Ishida M, Yanai H, Tsuta K,
Sekimoto M and Sugie T: Adipophilin expression is an independent
marker for poor prognosis of patients with triple-negative breast
cancer: An immunohistochemical study. PLoS One. 15:e02425632020.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rakha EA, Allison KH, Bu H, Ellis IO,
Foschini MP, Horii R, et al: Invasive breast carcinoma of no
special type. WHO Classification of Tumours. 5th edition. Breast
Tumours IARC; Lyon: pp. 102–109. 2019
|
|
13
|
Yoshikawa K, Ishida M, Yanai H, Tsuta K,
Sekimoto M and Sugie T: Prognostic significance of PD-L1-positive
cancer-associated fibroblasts in patients with triple-negative
breast cancer. BMC Cancer. 21:2392021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoshikawa K, Ishida M, Yanai H, Tsuta K,
Sekimoto M and Sugie T: Immunohistochemical analysis of CD155
expression in triple-negative breast cancer patients. PLoS One.
16:e02531762021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Elston CW and Ellis IO: Pathological
prognostic factors in breast cancer. I. The value of histological
grade in breast cancer: Experience from a large study with
long-term follow-up. Histopathology. 19:403–410. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Q, Ma G, Deng Y, Luo W, Zhao Y, Li W
and Zhou Q: Prognostic value of Ki-67 in patients with resected
triple-negative breast cancer: A meta-analysis. Front Oncol.
9:10682019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ogston KN, Miller ID, Payne S, Hutcheon
AW, Sarkar TK, Smith I, Schofield A and Heys SD: A new histological
grading system to assess response of breast cancers to primary
chemotherapy: Prognostic significance and survival. Breast.
12:320–327. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuniyoshi S, Miki Y, Sasaki A, Iwabuchi E,
Ono K, Onodera Y, Hirakawa H, Ishida T, Yoshimi N and Sasano H: The
significance of lipid accumulation in breast carcinoma cells
through perilipin 2 and its clinicopathological significance.
Pathol Int. 69:463–471. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pucer A, Brglez V, Payré C, Pungerčar J,
Lambeau G and Petan T: Group X secreted phospholipase A(2) induces
lipid droplet formation and prolongs breast cancer cell survival.
Mol Cancer. 12:1112013. View Article : Google Scholar : PubMed/NCBI
|
